5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with lomustine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castro, MG; Darling, JL; Lowenstein, PR; Maleniak, TC | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and lomustine
Article | Year |
---|---|
Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.
Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; beta-Galactosidase; Brain Neoplasms; Combined Modality Therapy; DNA, Recombinant; Drug Resistance, Neoplasm; Fas Ligand Protein; Galactosides; Ganciclovir; Gene Expression; Genetic Therapy; Genetic Vectors; Glioblastoma; Herpesvirus 1, Human; Humans; Indoles; Lomustine; Membrane Glycoproteins; Thymidine Kinase; Tumor Cells, Cultured | 2001 |